FDA: Abbott's Trilipix may not lower heart, stroke risk; new trial ordered
10 November 2011
Donna Young
Please Login to read the full article.
10 November 2011
Donna Young
Please Login to read the full article.
RELATED CONTENT
NEWS
- Isis partner Genzyme submits NDA for rare lipid disease drug
- Aegerion expects to file in US, Europe by year end for lomitapide for rare lipid disorder
- Santarus submits ulcerative colitis NDA, inks cholesterol drug deal with Shore
- Aegerion seeks US, European nods for lipid disorder drug
FEATURES
Other Informa Features
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
